Related Experiment Video
Updated: Jun 29, 2025

Antibiotic Dereplication Using the Antibiotic Resistance Platform
Published on: October 17, 2019
Antibiotic Development: Lessons from the Past and Future Opportunities
Michael S Kinch1, Zachary Kraft2, Tyler Schwartz2
1Center for Research Innovation in Biotechnology, Long Island University, Brookville, NY, 11548, USA. michael.kinch@liu.edu.
Antimicrobial resistance is a growing threat, yet private sector investment in new antibacterial drugs has remained stagnant. Few companies are developing these vital medical countermeasures, despite the urgent need.
Area of Science:
- Infectious Diseases
- Drug Development
- Antimicrobial Resistance
Background:
- Antimicrobial resistance (AMR) poses a significant global health challenge.
- The development of new medical countermeasures against bacterial infections is crucial.
Purpose of the Study:
- To assess the progress and trends in the development of antibacterial drugs from 2000 to 2021.
- To compare private sector activity in antibacterial drug development with other areas, such as oncology.
Main Methods:
- Analysis of clinical trial data from 2000 to 2021.
- Evaluation of the number of investigative drugs, their development stages, and the number of involved organizations.
Main Results:
- Private sector interest in oncology surged, while activity in antibacterial development remained stagnant.
- A declining number of organizations are actively involved in developing new antibacterial products.
- Many companies that previously developed antibacterial agents have exited the field.
Conclusions:
- The development of medical countermeasures against bacterial infections is not keeping pace with the growing threat of antimicrobial resistance.
- There is a concerning decline in organizational involvement and product development pipelines for new antibacterial drugs.
Related Concept Videos
Antibiotic Selection
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Lytic Cycle of Bacteriophages
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Synthetic Biology
Golden rice
Golden rice is a genetically modified...

